These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32238005)

  • 21. Antibiotic treatment in patients with sepsis: a narrative review.
    Plata-Menchaca EP; Ferrer R; Ruiz Rodríguez JC; Morais R; Póvoa P
    Hosp Pract (1995); 2022 Aug; 50(3):203-213. PubMed ID: 32627615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
    Hoo GSR; Liew YX; Kwa AL
    Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Pharmacology of Antibiotics.
    Eyler RF; Shvets K
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):1080-1090. PubMed ID: 30862698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Agent Dosing in Infants.
    Johnson JK; Laughon MM
    Clin Ther; 2016 Sep; 38(9):1948-60. PubMed ID: 27473383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations.
    Tu Q; Cotta M; Raman S; Graham N; Schlapbach L; Roberts JA
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1383-1399. PubMed ID: 34313180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.
    Owens RC; Shorr AF
    Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S23-30. PubMed ID: 19502225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized antibiotic therapy in the treatment of severe infections.
    Annoni F; Grimaldi D; Taccone FS
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):27-35. PubMed ID: 31755789
    [No Abstract]   [Full Text] [Related]  

  • 30. Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).
    Payne KD; Das A; Ndiulor M; Hall RG
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):139-149. PubMed ID: 29186999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial Pharmacokinetics and Pharmacodynamics in Older Adults.
    Benson JM
    Infect Dis Clin North Am; 2017 Dec; 31(4):609-617. PubMed ID: 29079151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of anti-infective agents in intensive care units: the potential role of a 'fast' pharmacology.
    Cattaneo D; Corona A; De Rosa FG; Gervasoni C; Kocic D; Marriott DJ
    Expert Rev Clin Pharmacol; 2020 Apr; 13(4):355-366. PubMed ID: 32320302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
    Dhaese SAM; Roberts JA; Carlier M; Verstraete AG; Stove V; De Waele JJ
    Int J Antimicrob Agents; 2018 Apr; 51(4):594-600. PubMed ID: 29277531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.